CAS: 54-92-2; N'-Isopropylisonicotinohydrazide

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号4813-04-1 1(Or 2)-(isopro... | CAS号54-85-3 异烟肼 | CAS号75-30-9 2-碘代丙烷 | CAS号75-26-3 2-溴丙烷

合成工艺路线路线简述

    异烟肼置于sodium Cyanoborohydride,溶剂黄146体系中,用 甲醇,正己烷 作为反应溶剂,化学反应 30.0H,反应生成 异丙烟肼
    参考文献:Discovery Of A Novel Series Of Indolyl Hydrazide Derivatives As Diacylglycerol Acyltransferase‐1 Inhibitors
    标题:Discovery Of A Novel Series Of Indolyl Hydrazide Derivatives As Diacylglycerol Acyltransferase‐1 Inhibitors
    摘要:研究人员合成了一系列新型酰肼衍生物,作为潜在的二酰基甘油酰基转移酶(dgat)抑制剂.其中,化合物 8U 和 8V 具有选择性和强效的 Dgat-1 抑制活性.此外,化合物 8U 还能剂量依赖性地抑制 Hepg2 细胞株中甘油三酯的合成.此外,用化合物 8U 进行口服脂质耐受性试验显示,与用车辆处理的对照组动物相比,血浆甘油三酯水平显著下降,这表明急性脂质挑战后甘油三酯的吸收延迟.
    DOI:10.1002/bkcs.10123

    海关参考信息

    专利信息


    专利号:US-4310535-A
    优先权日:1976-11-30
    标题:Combination of drugs and a method for the selective control of the immune reactions evoked in a host by the administration of antigens
    发明人:PIERPAOLI WALTER
    权利人:PIERPAOLI WALTER
    摘要:The invention concerns a new composition or combination of drugs effective to selectively control the immune reactions which are evoked in a host by the administration of antigens. It comprises active components capable of simultaneously blocking the alpha -adrenergic receptors of the cells for catecholamine, blocking the dopaminergic receptors of the cells and increasing the synthesis of serotonin. Preferred drug combinations according to the invention contain in association phentolamine, haloperidol, L-5-hydroxy-tryptophane and possibly dopamine.

    专利号:US-2005080260-A1
    优先权日:2003-04-22
    标 题 :Preparation of prodrugs for selective drug delivery
    发明人:MILLS RANDELL L; WU GUO-ZHANG
    摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.

    专利号:US-2008214827-A1
    优先权日:2004-02-03
    标 题:Synthesis of Cyanoimino-Benzoimidazoles
    发明人:GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
    权利人:EURO CELTIQUE SA
    摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.

    专利号:US-5519131-A
    优先权日:1991-04-15
    标题:Synthesis of pyridooxazinyl-indoles
    发明人:EFFLAND RICHARD C; DAVIS LARRY; OLSEN GORDON E
    权利人:HOECHST MARION ROUSSEL INC
    摘要:This application relates to a process for the preparation of indolylpyridooxazines of the formula wherein R1, R2 and R3 are as defined in the specification which comprises cyclizing compound of the formula in the presence of a strong base such as sodium hydride or potassium t-butoxide.

    专利号:US-7749985-B2
    优先权日:2006-09-15
    标 题 :Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
    发明人:GALLOP MARK A; XU FENG; PHAN THU; DILIP USHA; PENG GE
    权利人:XENOPORT INC
    摘要:Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, methods of making acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, methods of using acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, and pharmaceutical compositions comprising acyloxyalkyl carbamate prodrugs 3-aminopropylphosphinic acid and analogs thereof for treating diseases or disorders such as mild cognitive impairment, cognitive impairment associated with Alzheimer's disease Alzheimer's disease, depression, anxiety, and epilepsy are disclosed. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, which are suitable for oral administration and sustained release oral dosage forms are also disclosed.

    专利号:EP-3103803-B1
    优先权日:2008-10-27
    标 题 :Intermediates for the synthesis of mtor kinase inhibitors
    涟水金诚化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.lsjcchem.com
    电话: 0517-82328358👤
    📞涟水金诚化工有限公司 ⚠️参考联系方式

    销售电话:0517-82328358
    邮箱:sales@lsjcchem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [1] Shen W, et al. Molecules. 2014, 19(11):18620-31.

    合成参考文献


    摘要:Pharmaceutical Chemistry Journal, 30(750), 1996
    摘要:Journal of Pharmacology and Experimental Therapeutics., 119(444), 1957 []
    摘要:Nature., 185(532), 1960
    摘要:Acta Neurologia et Psychiatrica Belgica., 59(977), 1959
    摘要:Japanese Journal of Pharmacology., 13(186), 1963 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知